Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.090
-0.120 (-9.92%)
At close: Nov 16, 2026, 4:00 PM EST
1.110
+0.020 (1.83%)
Pre-market: Nov 17, 2026, 7:06 AM EST

Lisata Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
282.7215.9616.2122.5932.1524.65
Short-Term Investments
--15.0427.9437.0770.32
Cash & Short-Term Investments
282.7215.9631.2550.5469.2394.97
Cash Growth
1388.14%-48.93%-38.17%-27.00%-27.11%174.69%
Accounts Receivable
--0.9---
Other Receivables
-0.70.6-0.7-
Receivables
-0.71.5-0.7-
Prepaid Expenses
5.031.051.833.391.951.21
Total Current Assets
287.7517.734.5853.9271.8896.18
Property, Plant & Equipment
0.180.020.210.480.780.79
Goodwill
64.74-----
Other Intangible Assets
292.9-0.190.260.33-
Other Long-Term Assets
2.850.020.020.020.040.04
Total Assets
648.4117.743554.6973.0397.01

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
6.571.021.282.422.661.93
Accrued Expenses
13.852.054.1943.552.36
Current Portion of Leases
--0.140.170.180.23
Total Current Liabilities
20.423.075.616.596.384.52
Long-Term Leases
---0.140.310.49
Long-Term Deferred Tax Liabilities
29.44-----
Other Long-Term Liabilities
6.920.070.070.070.02-
Total Liabilities
56.773.145.696.86.715.01

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010
Additional Paid-In Capital
587.19580.24578.42576.97574.55546.04
Retained Earnings
-578.86-564.65-548.07-528.08-507.24-453.02
Treasury Stock
-0.71-0.71-0.71-0.71-0.71-0.71
Comprehensive Income & Other
0.01-0.04-0.08-0.04-0.03-0.07
Total Common Equity
7.6414.8629.5748.1566.5892.25
Minority Interest
--0.25-0.25-0.25-0.25-0.25
Shareholders' Equity
591.6414.629.3247.8966.3292
Total Liabilities & Equity
648.4117.743554.6973.0397.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
--0.140.310.490.71
Net Cash (Debt)
282.7215.9631.1150.2368.7494.26
Net Cash Growth
1388.14%-48.71%-38.07%-26.93%-27.07%177.64%
Net Cash Per Share
31.221.843.736.2213.2725.56
Filing Date Shares Outstanding
10.89.0327.78.3184.04
Total Common Shares Outstanding
10.88.838.418.157.873.99
Working Capital
267.3314.6328.9747.3365.4991.66
Book Value Per Share
0.711.683.525.918.4623.14
Tangible Book Value
-349.9914.8629.3847.8966.2492.25
Tangible Book Value Per Share
-32.391.683.495.888.4223.14
Machinery
-0.490.590.590.610.34
Leasehold Improvements
--0.070.070.10.09
SEC Filings: 10-K · 10-Q